The Utah Department of Commerce’s Division of Consumer Protection, through the Utah Attorney General’s Office, has filed a lawsuit against some of the nation’s major insulin manufacturers, claiming manufacturers participated in an alleged pricing scheme that makes the drug difficult to acquire for Utahns who suffer from diabetes. The suit says that manufacturers and pharmacy benefit managers conspired to inflate the price of insulin up to 1,000 percent over the past decade. It said the money that goes toward treating diabetes in Utah is $1.7 billion each year, one-fourth of the total money spent on healthcare in the state.
The 112-page filing names three Please log in to see the rest of this story.
